Pharmaceutical Group of the European Union (PGEU)

Other articles you might find interesting

about Access to Medicines

• Unveiling the Danish Presidency health priorities
• European Parliament stance on antimicrobial resistance

about Pharmaceuticals and Medicines

• Guido Rasi begins as new head of European Medicines Agency
• EPHA position on ’Information to Patients’

about Patient safety

• EPHA Briefing on Cross-border Patient Rights Directive
• EPHA briefing on eHealth

about Cross Border Healthcare Directive

• EPHA position on the Social Determinants of Health and the Health Divide in the WHO European Region
• European public opinion shows support for EU cooperation on rare diseases

about eHealth

• Digital Agenda: New coalition strives to keep children safe online
• EPHA Briefing on the Digital Agenda for Europe

about workforce

• Access denied: Irregular migrants excluded from basic rights and services in Europe
• "Keeping the Health Workforce debate high on the EU agenda is essential" argues EPHA in the European Parliament

about medical devices

• 2012 European Commission Work Programme: what priorities for the Commission in 2012?
• Medical devices: health ministers have their say

about professional mobility

• First EU Single Market Forum impacts on professional qualifications and public procurement
• Highlights from the 2011 World Health Assembly

about counterfeit

• How does European trade policy impact on public health?
• EU-India Free Trade Agreement may hinder access to essential medicines

about pharmacovigilance

• French ’Mediator’ scandal ’preventable’ by EU pharmacovigilance rule
• Fundación de Ciencias del Medicamento y Productos Sanitarios (Fundamed)

about health system

• Commission proposal for a simplified recognition regime of professional qualifications
• Release of ESWI Flu documentary

about Directive 36

• Public conference on modernisation of Professional Qualifications Directive
• European Parliament resolution calls for enhancing professional mobility

about EMA

• European Medicines Agency 2009 financial accounts blocked by the European Parliament
• Health Action International - Europe (HAI)